OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
OPKO Health (OPK) Misses Q4 EPS by 9c, Revenue Beats
February 24, 2022 4:56 PM ESTOPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.11), $0.09 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $401.3 million versus the consensus estimate of $329.83 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
... More